{"id":518382,"date":"2021-07-27T16:04:09","date_gmt":"2021-07-27T20:04:09","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/aspira-womens-health-inc-to-report-second-quarter-2021-financial-results-on-august-12\/"},"modified":"2021-07-27T16:04:09","modified_gmt":"2021-07-27T20:04:09","slug":"aspira-womens-health-inc-to-report-second-quarter-2021-financial-results-on-august-12","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/aspira-womens-health-inc-to-report-second-quarter-2021-financial-results-on-august-12\/","title":{"rendered":"Aspira Women\u2019s Health Inc. to Report Second Quarter 2021 Financial Results on August 12"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">AUSTIN, Texas, July  27, 2021  (GLOBE NEWSWIRE) &#8212; Aspira Women\u2019s Health, Inc. (Nasdaq: AWH), a bioanalytical-based women\u2019s health company, today announced that it will report financial results for the second quarter ended June 30, 2021 on Thursday, August 12, 2021, after the market close, followed by an investor conference call and webcast at 4:30 p.m. Eastern Time.<\/p>\n<table style=\"border-collapse: collapse;width:100%;border-collapse:collapse\">\n<tr>\n<td colspan=\"2\" style=\"vertical-align: top\">\n            <strong><br \/>\n              <u>Thursday, August 12 at 4:30 pm ET<\/u><br \/>\n            <\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top\">Domestic:<\/td>\n<td style=\"vertical-align: top\">877-407-4018<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top\">International:<\/td>\n<td style=\"vertical-align: top\">201-689-8471<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top\">Conference ID:<\/td>\n<td style=\"vertical-align: top\">13720544<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top\">Webcast:<\/td>\n<td style=\"vertical-align: top\">\n            <a href=\"https:\/\/shared.outlook.inky.com\/link?domain=public.viavid.com&amp;t=eyJ0eXAiOiJKV1QiLCJhbGciOiJFUzI1NiJ9.eJxtkFFrgzAUhf9LnkWpbVkRxuook44aGe3qLIJEk86riYqJzmXsvy_uZWzs9d7v3HvO-UCKEQEUeYjDlckCCB1Btr1EFoJGsb4hHHlXwiWzEDNY3rY1NK_bEcgI1C5aYchZ_2sw9EaFSqU6L3VSpxtyDoX9g6QONJRNdld2d0BvF6u1e-MaXfSMvGbg3EKq7BlRGWcjM6cWxs38JA-4uLzgisQPNRVc58tHfVjelzSe_H93Ao_5caPxae8mVaHDKtFhjAHHZ3EJwnd88l1c1esoeHpLxJknx82Eq73Gu3CKdoU-VP5qjiNZnzFBgGeE0p5Jabx0ZODbP619x__8AkdKdjY.MEQCIF9AopZEKrvRoR0iE8QOPHlx9wIg5tlIIDO3hnnRRouhAiBYtYpwOOigahUe1eGcr9heEcUt0M5WMrz7-90VEskIrg\" rel=\"nofollow noopener\" target=\"_blank\">http:\/\/public.viavid.com\/index.php?id=145272<\/a>\n          <\/td>\n<\/tr>\n<\/table>\n<p>\n        <strong>About Aspira Women\u2019s Health Inc.<\/strong><br \/>\n        <br \/>Aspira Women\u2019s Health Inc. (formerly known as Vermillion, Inc., Nasdaq: VRML) is transforming women\u2019s health with the discovery, development, and commercialization of innovative testing options and bio-analytical solutions that help physicians assess risk, optimize patient management, and improve gynecologic health outcomes for women. Aspira Women\u2019s Health is particularly focused on closing the ethnic disparity gap in ovarian cancer risk assessment and developing solutions for pelvic diseases such as pelvic mass risk assessment and endometriosis. OVA1\u00ae plus includes our FDA-cleared products, OVA1\u00ae and OVERA\u00ae, to detect risk of ovarian malignancy in women with adnexal masses. ASPIRA GenetiX<sup>TM<\/sup> testing offers both targeted and more comprehensive genetic testing options with a gynecologic focus. With over 10 years of expertise in ovarian cancer risk assessment, Aspira Women\u2019s Health is delivering a portfolio of pelvic mass products over a patient\u2019s lifetime with our cutting-edge research. The next generation of products in development are OVANEX<sup>TM<\/sup> and EndoCheck<sup>TM<\/sup>. Visit our website for more information at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=BaHrGrFX5MlWF4npydEulWBCY1Fra79H7Jem1qoEnA5ZS5nZybLic1PNQTf5JOEinYCgP-A9YuIB1uBzzZNjVQ==\" rel=\"nofollow noopener\" target=\"_blank\">www.aspirawh.com<\/a>.<\/p>\n<p>\n        <strong>Investor Relations Contact:<\/strong><br \/>\n        <br \/>Ashley R. Robinson <br \/>LifeSci Advisors, LLC <br \/>Tel: 617-430-7577<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=dhYgmdw_FJJ61HQfz64kldC7ctGV9wnH1MYb14GHV7odUNzr7Zo2w_VF2Aa96DgiDx_4yCiPper1ZO3ZlNh22v_xXOdFDkX2zxHOo0yiOsI=\" rel=\"nofollow noopener\" target=\"_blank\">arr@lifesciadvisors.com<\/a><\/p>\n<p \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI4NzU1NiM0MzE3MDAyIzUwMDA0NTYzNw==\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/1797bf9f-98ad-472a-a521-b322e1d6a626\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>AUSTIN, Texas, July 27, 2021 (GLOBE NEWSWIRE) &#8212; Aspira Women\u2019s Health, Inc. (Nasdaq: AWH), a bioanalytical-based women\u2019s health company, today announced that it will report financial results for the second quarter ended June 30, 2021 on Thursday, August 12, 2021, after the market close, followed by an investor conference call and webcast at 4:30 p.m. Eastern Time. Thursday, August 12 at 4:30 pm ET Domestic: 877-407-4018 International: 201-689-8471 Conference ID: 13720544 Webcast: http:\/\/public.viavid.com\/index.php?id=145272 About Aspira Women\u2019s Health Inc. Aspira Women\u2019s Health Inc. (formerly known as Vermillion, Inc., Nasdaq: VRML) is transforming women\u2019s health with the discovery, development, and commercialization of innovative testing options and bio-analytical solutions that help physicians assess risk, optimize patient management, and improve gynecologic health outcomes for &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/aspira-womens-health-inc-to-report-second-quarter-2021-financial-results-on-august-12\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Aspira Women\u2019s Health Inc. to Report Second Quarter 2021 Financial Results on August 12&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-518382","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Aspira Women\u2019s Health Inc. to Report Second Quarter 2021 Financial Results on August 12 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/aspira-womens-health-inc-to-report-second-quarter-2021-financial-results-on-august-12\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Aspira Women\u2019s Health Inc. to Report Second Quarter 2021 Financial Results on August 12 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"AUSTIN, Texas, July 27, 2021 (GLOBE NEWSWIRE) &#8212; Aspira Women\u2019s Health, Inc. (Nasdaq: AWH), a bioanalytical-based women\u2019s health company, today announced that it will report financial results for the second quarter ended June 30, 2021 on Thursday, August 12, 2021, after the market close, followed by an investor conference call and webcast at 4:30 p.m. Eastern Time. Thursday, August 12 at 4:30 pm ET Domestic: 877-407-4018 International: 201-689-8471 Conference ID: 13720544 Webcast: http:\/\/public.viavid.com\/index.php?id=145272 About Aspira Women\u2019s Health Inc. Aspira Women\u2019s Health Inc. (formerly known as Vermillion, Inc., Nasdaq: VRML) is transforming women\u2019s health with the discovery, development, and commercialization of innovative testing options and bio-analytical solutions that help physicians assess risk, optimize patient management, and improve gynecologic health outcomes for &hellip; Continue reading &quot;Aspira Women\u2019s Health Inc. to Report Second Quarter 2021 Financial Results on August 12&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/aspira-womens-health-inc-to-report-second-quarter-2021-financial-results-on-august-12\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-07-27T20:04:09+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI4NzU1NiM0MzE3MDAyIzUwMDA0NTYzNw==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aspira-womens-health-inc-to-report-second-quarter-2021-financial-results-on-august-12\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aspira-womens-health-inc-to-report-second-quarter-2021-financial-results-on-august-12\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Aspira Women\u2019s Health Inc. to Report Second Quarter 2021 Financial Results on August 12\",\"datePublished\":\"2021-07-27T20:04:09+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aspira-womens-health-inc-to-report-second-quarter-2021-financial-results-on-august-12\\\/\"},\"wordCount\":273,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aspira-womens-health-inc-to-report-second-quarter-2021-financial-results-on-august-12\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI4NzU1NiM0MzE3MDAyIzUwMDA0NTYzNw==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aspira-womens-health-inc-to-report-second-quarter-2021-financial-results-on-august-12\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aspira-womens-health-inc-to-report-second-quarter-2021-financial-results-on-august-12\\\/\",\"name\":\"Aspira Women\u2019s Health Inc. to Report Second Quarter 2021 Financial Results on August 12 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aspira-womens-health-inc-to-report-second-quarter-2021-financial-results-on-august-12\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aspira-womens-health-inc-to-report-second-quarter-2021-financial-results-on-august-12\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI4NzU1NiM0MzE3MDAyIzUwMDA0NTYzNw==\",\"datePublished\":\"2021-07-27T20:04:09+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aspira-womens-health-inc-to-report-second-quarter-2021-financial-results-on-august-12\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aspira-womens-health-inc-to-report-second-quarter-2021-financial-results-on-august-12\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aspira-womens-health-inc-to-report-second-quarter-2021-financial-results-on-august-12\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI4NzU1NiM0MzE3MDAyIzUwMDA0NTYzNw==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI4NzU1NiM0MzE3MDAyIzUwMDA0NTYzNw==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aspira-womens-health-inc-to-report-second-quarter-2021-financial-results-on-august-12\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Aspira Women\u2019s Health Inc. to Report Second Quarter 2021 Financial Results on August 12\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Aspira Women\u2019s Health Inc. to Report Second Quarter 2021 Financial Results on August 12 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/aspira-womens-health-inc-to-report-second-quarter-2021-financial-results-on-august-12\/","og_locale":"en_US","og_type":"article","og_title":"Aspira Women\u2019s Health Inc. to Report Second Quarter 2021 Financial Results on August 12 - Market Newsdesk","og_description":"AUSTIN, Texas, July 27, 2021 (GLOBE NEWSWIRE) &#8212; Aspira Women\u2019s Health, Inc. (Nasdaq: AWH), a bioanalytical-based women\u2019s health company, today announced that it will report financial results for the second quarter ended June 30, 2021 on Thursday, August 12, 2021, after the market close, followed by an investor conference call and webcast at 4:30 p.m. Eastern Time. Thursday, August 12 at 4:30 pm ET Domestic: 877-407-4018 International: 201-689-8471 Conference ID: 13720544 Webcast: http:\/\/public.viavid.com\/index.php?id=145272 About Aspira Women\u2019s Health Inc. Aspira Women\u2019s Health Inc. (formerly known as Vermillion, Inc., Nasdaq: VRML) is transforming women\u2019s health with the discovery, development, and commercialization of innovative testing options and bio-analytical solutions that help physicians assess risk, optimize patient management, and improve gynecologic health outcomes for &hellip; Continue reading \"Aspira Women\u2019s Health Inc. to Report Second Quarter 2021 Financial Results on August 12\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/aspira-womens-health-inc-to-report-second-quarter-2021-financial-results-on-august-12\/","og_site_name":"Market Newsdesk","article_published_time":"2021-07-27T20:04:09+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI4NzU1NiM0MzE3MDAyIzUwMDA0NTYzNw==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aspira-womens-health-inc-to-report-second-quarter-2021-financial-results-on-august-12\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aspira-womens-health-inc-to-report-second-quarter-2021-financial-results-on-august-12\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Aspira Women\u2019s Health Inc. to Report Second Quarter 2021 Financial Results on August 12","datePublished":"2021-07-27T20:04:09+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aspira-womens-health-inc-to-report-second-quarter-2021-financial-results-on-august-12\/"},"wordCount":273,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aspira-womens-health-inc-to-report-second-quarter-2021-financial-results-on-august-12\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI4NzU1NiM0MzE3MDAyIzUwMDA0NTYzNw==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aspira-womens-health-inc-to-report-second-quarter-2021-financial-results-on-august-12\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/aspira-womens-health-inc-to-report-second-quarter-2021-financial-results-on-august-12\/","name":"Aspira Women\u2019s Health Inc. to Report Second Quarter 2021 Financial Results on August 12 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aspira-womens-health-inc-to-report-second-quarter-2021-financial-results-on-august-12\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aspira-womens-health-inc-to-report-second-quarter-2021-financial-results-on-august-12\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI4NzU1NiM0MzE3MDAyIzUwMDA0NTYzNw==","datePublished":"2021-07-27T20:04:09+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aspira-womens-health-inc-to-report-second-quarter-2021-financial-results-on-august-12\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/aspira-womens-health-inc-to-report-second-quarter-2021-financial-results-on-august-12\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aspira-womens-health-inc-to-report-second-quarter-2021-financial-results-on-august-12\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI4NzU1NiM0MzE3MDAyIzUwMDA0NTYzNw==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI4NzU1NiM0MzE3MDAyIzUwMDA0NTYzNw=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aspira-womens-health-inc-to-report-second-quarter-2021-financial-results-on-august-12\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Aspira Women\u2019s Health Inc. to Report Second Quarter 2021 Financial Results on August 12"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/518382","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=518382"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/518382\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=518382"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=518382"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=518382"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}